EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression

Mirela Ambeskovic, Giselle Hopkins, Tanzi Hoover, Jeffrey T Joseph, Tony Montina iD, Gerlinde A S Metz iD

International Journal of Molecular Sciences · 30.09.2023 · 24 (19) · 14769

DOI: 10.3390/ijms241914769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2023. Verfasst von Mirela Ambeskovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Canadian Centre for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Alberta Innovates, Alberta Innovates fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological mechanisms contributing to Alzheimer’s disease (AD) are still elusive. Here, we identified the metabolic signatures of AD in human post-mortem brains. Using 1H NMR spectroscopy and an untargeted metabolomics approach, we identified (1) metabolomic profiles of AD and age-matched healthy subjects in post-mortem brain tissue, and (2) region-common and region-unique metabolome alterations and biochemical pathways across eight brain regions revealed that BA9 was the most affected. Phenylalanine and phosphorylcholine were mainly downregulated, suggesting altered neurotransmitter synthesis. N-acetylaspartate and GABA were upregulated in most regions, suggesting higher inhibitory activity in neural circuits. Other region-common metabolic pathways indicated impaired mitochondrial function and energy metabolism, while region-unique pathways indicated oxidative stress and altered immune responses. Importantly, AD caused metabolic changes in brain regions with less well-documented pathological alterations that suggest degenerative progression. The findings provide a new understanding of the biochemical mechanisms of AD and guide biomarker discovery for personalized risk prediction and diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansBrainMetabolomicsMetabolomeMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

GABAagingcognitive functionenergy metabolismglucose metabolismmitochondrial dysfunctionneurodegenerative diseaseneuropathologyneurotransmissionoxidative stressphenylalanineproton nuclear magnetic resonance (1H NMR) spectroscopy

Autor:innen und Institutionen

  • Canadian Centre for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
  • Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
  • Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
  • Southern Alberta Genome Sciences Centre, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.

ORCID-Profile: Tony Montina, Gerlinde A S Metz

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Alberta Innovates
  • Alberta Innovates fellowship

Zitieren

APA

Ambeskovic, M., Hopkins, G., Hoover, T., Joseph, J. T., Montina, T., & Metz, G. A. S. (2023). Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression. International Journal of Molecular Sciences, 24(19), 14769. https://doi.org/10.3390/ijms241914769

Vancouver

Ambeskovic M, Hopkins G, Hoover T, Joseph JT, Montina T, Metz GAS. Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression. International Journal of Molecular Sciences. 2023;24(19):14769. doi:10.3390/ijms241914769

BibTeX
@article{Ambeskovic2023,
  author = {Ambeskovic, Mirela and Hopkins, Giselle and Hoover, Tanzi and Joseph, Jeffrey T and Montina, Tony and Metz, Gerlinde A S},
  title = {Metabolomic Signatures of Alzheimer’s Disease Indicate Brain Region-Specific Neurodegenerative Progression},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {19},
  pages = {14769},
  doi = {10.3390/ijms241914769}
}
Kostenlos starten →